Session Details

IWPCT_MR1_1

Mon. Jun 1, 2026 10:00 AM - 12:30 PM JST
Mon. Jun 1, 2026 1:00 AM - 3:30 AM UTC
Room 1(Large Conference Room, 4F)
Chair:Milica Živanić(Universitat Politecnica de Catalunya)

[21001]Screening campaigns in plasma medicine – identifying best drug combinations, oxidation-sensitive molecules, and biological mechanisms

*Sander Bekeschus1,2, Debora Singer1, Ramona Clemen1, Anke Schmidt1, Klaus-Dieter Weltmann1, Thomas von Woedtke1,3, Kristian Wende1 (1. Leibniz Institute for Plasma Science and Technology (Germany), 2. Rostock University Medical Center (Germany), 3. Greifswald University Medical Center (Germany))

[21002]Antitumor effects by repeated PAL treatment in MCF-7 cells

*Ryo Wakatsukasa1, Ayako Tanaka2, Camelia Miron2, Kae Nakamura2,3, Kenji Ishikawa1,2, Masaru Hori2, Hiromasa Tanaka1,2 (1. Department of Electronics, Graduate school of Engineering, Nagoya University (Japan), 2. Center for Low-temperature Plasma Sciences, Nagoya University (Japan), 3. Department of Obstetrics and Gynecology, Graduate school of Medicine, Nagoya University (Japan))

[21003]Combining microfluidics with cold physical plasma as a new theragnostic platform for personalized cancer redox therapy

*Juliette Letellier-Bao1, Roxanne Thomas1, Lisa Hermans3, Derek Rosenzweig2, Thomas Gervais1, Daria Boffito1, Sylvain Coulombe2, Annemie Bogaerts3, Stephan Reuter1 (1. Polytechnique Montréal (Canada), 2. McGill University (Canada), 3. University of Antwerp (Belgium))

[21004]Redox Transcriptional Regulation of PD-L1 Expression By Cold Atmospheric Microplasma

*Otoha Shimmachi1, Rubaiya Islam1, Farhana Begum1, Abubakar Hamza Sadiq1, Mahedi Hasan1, Md Jahangir Alam1, Jaroslav Kristof1, Kazuo Shimizu1 (1. Shizuoka University (Japan))

[21005]Innovative In-vivo Approach: Combining Ultrasound and Plasma-Activated Lactated Ringer's Solution for the Treatment of Disseminated Intra-abdominal Malignancies

*Loreto B. Feril1, Hiroshi Kida1, Yutaro Yamasaki1, Takayuki Koga1, Hitomi Endo1, Takashi Kondo2, Hiromasa Tanaka2, Katsuro Tachibana3 (1. Fukuoka University School of Medicine (Japan), 2. Nagoya University (Japan), 3. Fukuoka University General Medical Research Center (Japan))

[21006]Precisely controlled multimode CAP exposure for cancer treatment

*Irina Schweigert1 (1. Khristianovich Institute of Theoretical and Applied Mechanics, SB RAS (Russia))

[21007]Cold Atmospheric Plasma Disrupts CAF-Mediated Support in the Breast Tumour Microenvironment

*Giulia Fornabaio1 (1. Universitat Politècnica de Catalunya-Barcelonatech (UPC) (Spain))

[21008]Numerical Modeling of Plasma Stimulation in Immunogenic Responses

*Tomoyuki Murakami1 (1. Seikei University (Japan))

[21009]Antitumor Effects of Plasma-Activated PBS in Breast Cancer Cell 2D and 3D Models

Darina Kužmová1, Helena Gbelcová2, *Zdenko Machala1 (1. Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics (Slovakia), 2. Comenius University Bratislava, Faculty of Medicine (Slovakia))